COLL - コレギウム・ファ―マシュ―ティカル (Collegium Pharmaceutical Inc.)


   Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2019 Results - Earnings Call Transcript  2019-05-08
Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Conference Call May 8, 2019, 04:30 PM ET Company Participants Alex Dasalla - Head, IR Joe Ciaffoni - CEO Paul Brannelly - CFO Scott Dreyer - Chief Commercial Officer Conference Call Participants Tim Lugo - William Bla…
   Goldman adds Exact Sciences to Conviction List in premarket analyst action  2019-04-12
Exact Sciences (NASDAQ: EXAS ) added to Goldman Sachs Conviction List. More news on: Exact Sciences Corporation, AtriCure, Inc., Collegium Pharmaceutical, Inc., Healthcare stocks news, , Read more …